1
Seppo Pienimaa, Xia Wang, Kong Qiao Wang, Antti Salo, Tapani Levola: Display apparatus and device. Nokia Corporation, Perman & Green, August 16, 2011: US07997723 (27 worldwide citation)

A near-eye display related apparatus and device is disclosed. The apparatus includes a housing configured to receive an optical engine, and a light guiding plate attached to the housing and configured to receive light representing an image from the optical engine, the light guiding plate includes a ...


2
Pingda Ren, Xia Wang, Guobao Zhang, Qiang Ding, Shuli You, Qiong Zhang, Greg Chopiuk, Pamela A Albaugh, Taebo Sim, Nathanael Schiander Gray: Compounds and compositions as protein kinase inhibitors. IRM, Scott W Reid, Genomics Institute of the Novartis Research Foundation, June 29, 2010: US07745437 (17 worldwide citation)

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal act ...


3
Taebo Sim, Hyun Soo Lee, Pingda Ren, Qiang Ding, Yi Liu, Bing Li, Lintong Li, Xia Wang, Tetsuo Uno, Guobao Zhang, Nathanael Schiander Gray, Shuli You: Compounds and compositions as protein kinase inhibitors. IRM, Scott W Reid D Phil, Genomics Institute of the Novartis Research Foundation, January 5, 2010: US07642255 (9 worldwide citation)

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal act ...


4
Taebo Sim, Hyun Soo Lee, Pingda Ren, Qiang Ding, Guobao Zhang, Yi Liu, Xia Wang, Tetsuo Uno, Bing Li, Lintong Li, Nathanael Schiander Gray, Shuli You: Compounds and compositions as protein kinase inhibitors. IRM, Scott W Reid, Genomics Institute of the Novartis Research Foundation, May 13, 2008: US07371750 (7 worldwide citation)

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal act ...


5
Chaoqun Sun, Xia Wang, Jinxiang Shen: Dimmable LED lamp and dimming method. SENGLED OPTOELECTRONICS, Anova Law Group PLLC, April 5, 2016: US09307604 (5 worldwide citation)

A dimmable light emitting diode (LED) lamp is provided. The dimmable LED lamp includes an alternating current (AC) input unit and at least one AC detection unit connected to the AC input unit. The dimmable LED lamp also includes at least one LED driving and power supply unit and at least one LED lig ...


6
Pingda Ren, Francisco Adrian, Nathanael S Gray, Xia Wang: Cyclic compounds and compositions as protein kinase inhibitors. IRM, Genomics Institute of the Novartis Research Foundation, Scott W Reid, December 19, 2006: US07151096 (5 worldwide citation)

The invention provides a novel class of cyclic compounds, pharmaceutical compositions comprising such cyclic compounds and methods of using such compounds to treat or prevent diseases and disorders associated with cyclin-dependent kinases (CDKs) activity, particularly diseases associated with the ac ...


7
Guobao Zhang, Pingda Ren, Xia Wang, Nathanel Gray, Taebo Sim: Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors. Novartis, Scott W Reid, April 23, 2013: US08426404 (3 worldwide citation)

The invention provides a novel class of compounds having Formula Ia, wherein each variable is as defined; and pharmaceutical compositions comprising such compounds and methods of using such compounds for inhibiting c-Src, FGFR3, KDR and/or Lck.


8
Pingda Ren, Xia Wang, Nathanael Schiander Gray, Yi Liu, Taebo Sim: Compounds and compositions as protein kinase inhibitors. IRM, Scott W Reid, Genomics Institute of the Novartis Research Foundation, September 9, 2008: US07423038 (3 worldwide citation)

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders than involve abnormal act ...


9
Wei Wang, Kongqiao Wang, Xiaohui Xie, Yingfei Liu, Xia Wang, Huanglingzi Liu, Bin Wang, Zhen Liu, Yuezhong Tang: User input. Nokia Technologies Oy, Alston & Bird, January 12, 2016: US09235341 (2 worldwide citation)

Apparatus, a method and a computer program are provided. The apparatus includes: at least one processor; and at least one memory storing computer program instructions, the at least one processor being configured to execute the computer program instructions to cause the apparatus at least to perform: ...


10
Pamela Albaugh, Gregory B Chopiuk, Qiang Ding, Shenlin Huang, Zuosheng Liu, Shifeng Pan, Pingda Ren, Xia Wang, Xing Wang, Yongping Xie, Chengzhi Zhang, Qiong Zhang, Guobao Zhang, Daniel Poon, Paul Renhowe, Martin Sendzik: Compounds and compositions as protein kinase inhibitors. IRM, Novartis, Daniel E Raymond, Genomics Institute of the Novartis Research Foundation, June 19, 2012: US08202876 (2 worldwide citation)

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal act ...